COST-EFFECTIVENESS OF LIPOSOMAL IRINOTECAN (nal-IRI) COMBINED WITH 5-FLUOROURACIL AND LEUCOVORIN IN SECOND OR SUBSEQUENT LINES FOR METASTATIC PANCREATIC CANCER IN ITALY. IT CAN BE DONE.
13 Aug 2025, noon
Publication date: Available online 12 August 2025Source: PancreatologyAuthor(s): Jacopo Giuliani, ...